FindTrial
Sign In

The use of biphasic energy for cardioversion of atrial fibrillation under midazolam sedation. A comparison of results using monophasic and biphasic energies with short acting general anaesthesia (GA) and midazolam sedation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN48624113
Enrollment
Unknown
Registered
2003-09-12
Start date
2001-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Atrial fibrillation (AF) Circulatory System Atrial fibrillation (AF)

Interventions

Group 1 - Monophasic direct current cardioversion (DCCV) with midazolam sedation Group 2 - Biphasic DCCV with midazolam sedation Group 3 - Monophasic DCCV with short acting GA (propofol) Group 4 - B

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults with atrial fibrillation

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Side effects of higher energy 2. Efficacy 3. Patient tolerance 4. Quantity of drugs 5. Length of stay in hospital (day case)—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026